Predictors of early mortality in patients age 80 and older receiving implantable defibrillators

PACE - Pacing and Clinical Electrophysiology

Volumn 33, Issue 8, 2010, Pages 981-987

  Ertel, Drew ^a   Phatak, Kavita ^a   Makati, Kevin ^b   Holland, Marian ^a   Baig, Sara ^b   Kim, Michael H ^a   Link, Mark ^b   Passman, Rod ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

geriatrics; ICDs; octogenarian; sudden cardiac death

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; SPIRONOLACTONE;

AGED; ARTICLE; COHORT ANALYSIS; DEFIBRILLATOR; DRUG UTILIZATION; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HEART EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SURVIVAL TIME; TREATMENT INDICATION;

AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; RISK FACTORS; SURVIVAL RATE;

EID: 77955292220     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2010.02729.x     Document Type: Article

References (36)

1. http://www.ncdr.com (National Cardiovascular Data Registry); accessed November 26, 2008.
2. Ho K, Anderson K, Kannel W, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993 88.1 : 107 115.
3. Cicoira M, Davos C, Florea V, Shamim W, Doehner W, Coats A, Anker S. Chronic heart failure in the very elderly: Clinical status, survival, and prognostic factors in 188 patients more than 70 years old. Am Heart J 2001 142 : 174 180.
4. Lee D, Austin P, Rouleau J, Liu P, Naimark D, Tu J. Predicting mortality among patients hospitalized for heart failure. JAMA 2003 290 : 2581 2587.
5. Mosterd A, Cost B, Hoes A, de Bruijne M, Deckers J, Hofman A, Grobbee D. The prognosis of heart failure in the general population. Eur Heart J 2001 22 : 1318 1327.
6. Jong P, Vowinckel E, Liu P, Gong Y, Tu J. Prognosis and determinants of survival in patients newly hospitalized for heart failure. Arch Internal Med 2002 162 : 1689 1694.
7. Gottdiener J, McClelland R, Marshall R, Shemanski L, Furberg C, Kitzman D, Cushman M, et al. Outcome of congestive heart failure in elderly patients: Influence of left ventricular systolic function. Ann Internal Med 2002 137 : 631 639.
8. Gustafsson F, Torp-Pedersen C, Brendorp B, Seibaek M, Burchardt H, Kober L. Long-term survival in patients hospitalized with congestive heart failure: Relation to preserved and reduced left ventricular systolic function. Eur Heart J 2003 24 : 863 870. (Pubitemid 36528566)
9. Quinones M, Greenberg B, Kopelen H, Koilpillai C, Limacher M, Shindler D, Shelton B, et al. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD Registry and Trials: Significance of left ventricular hypertrophy. J Am College Cardiol 2000 35 : 1237 1244.
10. Solomon S, Anavekar N, Skali H, McMurray J, Swedberg K, Yusuf S, Granger C, et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 2005 112 : 3738 3744.
11. Wong M, Staszewsky L, Latini R, Barlera S, Glazer R, Aknay N, Hester A, et al. Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure. J Am College Cardiol 2004 43 : 2022 2027.
12. Kerzner R, Gage B, Freedland K, Rich M. Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction. Am Heart J 2003 146 : 286 290.
13. McDermott M, Feinglass J, Lee P, Mehta S, Schmitt B, Lefevre F, Gheorghiade M. Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure. Am Heart J 1997 134 : 728 736.
14. Cowie M, Wood D, Coats A, Thompson S, Suresh V, Poole-Wilson P, Sutton G. Survival of patients with a new diagnosis of heart failure: A population based study. Heart 2000 83 : 505 510.
15. Pernenkil R, Vinson J, Shah A, Beckham V, Wittenberg C, Rich M. Course and prognosis in patients ≥ 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol 1997 79 : 216 219.
16. Tsutsui H, Tsuchihashi M, Takeshita A. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol 2001 88 : 530 533.
17. Pulignano G, Del Sindaco D, Tavazzi L, Lucci D, Gorini M, Leggio F, Porcu M, et al. Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: Data from a large nationwide cardiology database (IN-CHF Registry). Am Heart J 2002 143 : 45 55.
18. Lee D, Tu J, Austin P, Dorian P, Yee R, Chong A, Alter D, et al Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am College Cardiol 2007 49 : 2408 2415.
19. Gustafsson F, Torp-Pedersen C, Seibaek M, Burchardt H, Kober L. Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure. Eur Heart J 2004 25 : 1711 1717.
20. Wang R, Mouliswar M, Denman S, Kleban M. Mortality of the institutionalized old-old hospitalized with congestive heart failure. Arch Internal Med 1998 158 : 2464 2468.
21. Moss A, Hall W, Cannom D, Daubert J, Higgins S, Klein H, Levine J, et al. for the Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. New England J Med 1996 335 : 1933 1940.
22. Buxton AE, Lee KL, Fisher JD, Josephson M, Prystowsky E, Hafley G. The Multicenter Unsustained Tachycardia Trial Investigators: A randomized study of the prevention of sudden death in patients with coronary artery disease. New England J Med 1999 341 : 1882 1890.
23. Moss A, Zareba W, Hall W, Klein H, Wilber D, Cannom D, Daubert J, et al. for the MADIT II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England J Med 2002 346 : 877 883.
24. Kadish A, Dyer A, Daubert J, Quigg R, Estes M, Anderson K, Calkins H, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. New England J Med 2004 350 : 2151 2158.
25. Bardy G, Kee K, Mark D, Poole J, Packer D, Boineau R, Domanski M, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England J Med 2005 352 : 225 237.
26. Daubert J, Sesselberg H, Huang D. Implantable cardioverter-defibrillators for primary prevention: How do the data pertain to the aged? Am J Geriatric Cardiol 2006 15 : 88 92.
27. Peterson M, Packer D, Hafley G, Lee K, Buxton A. Do elderly benefit from defibrillator as primary prevention in coronary artery disease and left ventricular dysfunction. Pacing Clin Electrophysiol 2003 26 (part II) 973.
28. Huang D, Sesselberg H, McNitt S, Noyes K, Andrews M, Hall W, Dick A, et al. improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: A MADIT-II substudy. J Cardiovasc Electrophysiol 2007 18 : 833 838.
29. Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M, on behalf of the CIDS Investigators. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy. The Canadian implantable defibrillator study. Circulation 2000 101 : 1660 1664.
30. Healey J, Hallstrom A, Kuck K, Nair G, Schron E, Roberts R, Morillo C, et al. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J 2007 28 : 1746 1749.
31. Koplan B, Epstein L, Albert C, Stevenson W. Survival in octogenarians receiving implantable defibrillators. Am Heart J 2006 156 : 714 719.
32. Krahn A, Connolly S, Roberts R, Gent M, for the ATMA Investigators. Diminishing proportional risk of sudden death with advancing age: Implications for prevention of sudden death. Am Heart J 2004 17 : 837 840.
33. Parkash R, Stevenson W, Epstein L, Maisel W. Predicting early mortality after implantable defibrillator implantation: A clinical risk score for optimal patient selection. Am Heart J 2005 151 : 397 403.
34. Goldenberg I, Vyas A, Hall W, Moss A, Wang H, He H, Zareba W, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am College Cardiol 2008 51 : 288 296.
35. Zwanziger J, Hall W, Dick A, Zhao H, Mushlin A, Hahn R, Wang H, et al. The cost-effectiveness of implantable cardioverter-defibrillators: Results from the multicenter automatic defibrillator implantation trial (MADIT)-II. J Am College Cardiol 2006 47 : 2310 2318.
36. Eberhardt F, Bode F, Bonnemeier H, Boguschewski F, Schlei M, Peters W, Wiegand U. Long-term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity. Heart 2005 91 : 500 506.